CAR-T cell therapy for liver metastases
Liver metastases are the most common cause of death in colorectal cancer patients. The standard of care and potential for cure for colorectal liver metastases is resection, but often times disease it too extensive for this treatment. Over the years, cancer research has made way for advances in treat...
Main Author: | Lashtur, Nelya |
---|---|
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/19196 |
Similar Items
-
Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer
by: Ke-Tao Jin, et al.
Published: (2021-02-01) -
Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
by: Daniel Sur, et al.
Published: (2020-01-01) -
Tuning the performance of CAR T cell immunotherapies
by: Noah H. Richardson, et al.
Published: (2019-11-01) -
CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
by: Li-Na Zhang, et al.
Published: (2018-03-01) -
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
by: Matteo Donadon, et al.
Published: (2018-05-01)